25 related articles for article (PubMed ID: 6382720)
1. Glucocorticoid inhibitory action on the response to PHA of residual circulatory lymphocytes in renal transplant patients following immunosuppressive therapy.
Musiani P; Citterio F; Maggiano N; Pozzetto U; Lauriola L; Luciani G; Ranelletti FO; Castagneto M; Piantelli M
Clin Exp Immunol; 1984 Jan; 55(1):217-23. PubMed ID: 6362935
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
[No Abstract] [Full Text] [Related]
3. Cyclosporin-A and the OKT3 monoclonal antibody exert their respective inhibitory and mitogenic activity on T cells by interacting with the same receptors.
Palacios R
J Clin Immunol; 1982 Jul; 2(3 Suppl):15S-19S. PubMed ID: 6982278
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic effects of everolimus on anti-CD3 antibody-stimulated T-lymphocyte proliferation and interleukin-10 synthesis in stable kidney-transplant patients.
Böhler T; Waiser J; Lichter S; Schumann B; Neumayer HH; Kamar N; Budde K
Cytokine; 2008 Jun; 42(3):306-11. PubMed ID: 18440821
[TBL] [Abstract][Full Text] [Related]
5. Monitoring immunosuppression following renal transplantation.
Giorgi JV; Cosimi AB; Colvin RB; Goldstein G; Delmonico FL; Russell PS
Diagn Immunol; 1983; 1(3):174-8. PubMed ID: 6388969
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid inhibitory action on OKT3-stimulated peripheral blood lymphocytes from renal transplant patients.
Musiani P; Citterio F; Maggiano N; Pozzetto U; Lauriola L; Ranelletti FO; Aiello FB; Piantelli M
Transplantation; 1984 Sep; 38(3):309-12. PubMed ID: 6382720
[No Abstract] [Full Text] [Related]
7. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
Bonnefoy-Berard N; Revillard JP
J Heart Lung Transplant; 1996 May; 15(5):435-42. PubMed ID: 8771497
[TBL] [Abstract][Full Text] [Related]
8. T-cell depletion for transplant tolerance induction: promises and hurdles.
Dumont FJ
Curr Opin Investig Drugs; 2003 Nov; 4(11):1275-8. PubMed ID: 14758765
[No Abstract] [Full Text] [Related]
9. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
Buhaescu I; Segall L; Goldsmith D; Covic A
J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
[TBL] [Abstract][Full Text] [Related]
10. The clinical application of monoclonal antibody therapies in renal transplantation.
Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
[TBL] [Abstract][Full Text] [Related]
11. New insights into therapy with monoclonal antibodies in allograft transplantation.
Schena FP
Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
[No Abstract] [Full Text] [Related]
12. Pharmacological control of the immune response in renal transplantation.
Warrens AN
BJU Int; 2002 Nov; 90(8):784-91. PubMed ID: 12406112
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
